Citron Research tweeted on July 19 that AbbVie is the next great drug short.
Morningstar is out with their lists of the highest-yielding and widely-held
Current portfolio holding AbbVie (ABBV) is taking a hit today after announcing
This is from the AMM Dividend Letter released February 28, 2014. If you